Insulin biosynthesis
Similar to other neuroendocrine peptide hormones, insulin is initially synthesized as a larger precursor molecule called proinsulin. Proinsulin is processed into mature, secreted insulin through a series of enzyme-mediated proteolytic cleavages.
We are interested in understanding how beta cells adjust their insulin translation and processing capacities in response to various stimuli present in acute nutrient overload and chronic diabetogenic milieu.
Reference:
Prohormone processing defects and T1D
Despite experiencing targeted attacks by immune cells, some pancreatic beta cells survive in individuals living with type 1 diabetes (T1D). These residual beta cells continue to produce proinsulin and other peptide hormones, such as pro-islet amyloid polypeptide (IAPP).
We are interested in understanding the impact of elevated peptide hormone production and impaired processing on beta cell integrity and susceptibility to autoimmunity. Specifically, we aim to investigate whether an increased insulin biosynthesis burden compromises beta-cell function, whether unprocessed or partially processed peptide hormones become neoepitopes or form hybrid peptides, and whether these events further promote beta cell death and antigen spreading.
Reference:
Islet amyloid clearance
IAPP is the second most abundant peptide hormone secreted by pancreatic beta cells. Human IAPP aggregates to form islet amyloid plaques in the pancreas, contributing to islet inflammation and beta cell death.
We are interested in understanding how human IAPP aggregates are removed both intracellularly and extracellularly, and whether defects in islet amyloid clearance lead to increased islet inflammation in obesity and diabetes or to islet graft failure in islet transplantation.
Reference:
See the full list of our peer-reviewed publications here.